Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: Comparison with obese subjects

International Journal of Obesity

Volumn 30, Issue 2, 2006, Pages 382-387

  Kennedy, L ^a   Bittel, D C ^b   Kibiryeva, N ^b   Kalra, S P ^a   Torto, R ^a   Butler, M G ^b,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Adiponectin; Body composition; Insulin resistance and sensitivity; Obesity related variables; Prader Willi syndrome (PWS); Simple obesity

Indexed keywords

ADIPONECTIN; C PEPTIDE; CHOLESTEROL; LEPTIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLIC SYNDROME X; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BODY FAT DISTRIBUTION; C-PEPTIDE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; OBESITY; PRADER-WILLI SYNDROME; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 32544449194     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803115     Document Type: Article

References (28)

1. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 1990; 35: 319-332.
2. Cassidy SB. Prader-Willi syndrome. J Med Genet 1997; 34: 917-923.
3. Butler MG, Thompson T. Prader-Willi syndrome: clinical and genetic findings. Endocrinology 2000; 10: 35-165.
4. Mascari MJ, Gottlieb W, Rogan PK, Butler MG, Waller DA, Armour JA et al. The frequency of uniparental disomy in Prader-Willi syndrome. Implications for molecular diagnosis. N Engl J Med 1992; 326: 1599-1607.
5. Glenn CC, Driscoll DJ, Yang TP, Nicholls RD. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol Hum Reprod 1997; 3: 321-332.
6. Robinson WP, Kuchinka BD, Bernasconi F, Petersen MB, Schulze A, Brondum-Nielsen K et al. Maternal meiosis I non-disjunction of chromosome 15: dependence of the maternal age effect on level of recombination. Hum Mol Genet 1998; 7: 1011-1019.
7. Ohta T, Gray TA, Rogan PK, Buiting K, Gabriel JM, Saitoh S et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet 1999; 64: 397-413.
8. Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, el-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet 2003; 72: 571-577.
9. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
10. Argiles JM, Lopez-Soriano J, Almendro V, Busquets S, Lopez-Soriano FJ. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med Res Rev 2004.
11. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
12. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50: 1511-1525.
13. Phillips SA, Ciaraldi TP, Kong AP, Bandukwala R, Aroda V, Carter L et al. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes 2003; 52: 667-674.
14. Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab 2001; 86: 4330-4338.
15. Hoybye C, Bruun JM, Richelsen B, Flyvbjerg A, Frystyk J. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment. Eur J Endocrinol 2004; 151: 457-461.
16. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr 1990; 51: 1106-1112.
19. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
20. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
21. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
22. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003; 88: 2014-2018.
23. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004; 27: 547-552.
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
25. Lebovitz H. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S135-S148.
26. Martin A, State M, Koenig K, Schultz R, Dykens EM, Cassidy SB et al. Prader-Willi syndrome. Am J Psychiatry 1998; 155: 1265-1273.
27. Talebizadeh Z, Butler M. Insulin resistance and obesity-related factors in Prader-Willi syndrome: Comparison with obese subjects. Clin Genet 2005; 67: 230-239.
28. Meaney FJ, Butler MG. Characterization of obesity in the Prader-Labhart-Willi syndrome: Fatness patterning. Med Anthropo Quart 1989; 3: 294-305.